Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.120
+0.010 (0.48%)
Jan 23, 2025, 12:24 PM EST - Market open
IMRX's stock price has decreased by -64.3% in the past year and price targets may not have had time to catch up.
Immuneering Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$12.80
Upside
+503.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Jan 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +513.18% | Jan 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Jan 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +513.18% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Sep 13, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $16 → $12 | Strong Buy | Maintains | $16 → $12 | +466.01% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Aug 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | May 8, 2024 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +607.51% | Apr 12, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $20 → $8 | Strong Buy | Maintains | $20 → $8 | +277.34% | Apr 2, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $16 → $3 | Strong Buy → Hold | Downgrades | $16 → $3 | +41.50% | Mar 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $21 → $16 | Strong Buy | Maintains | $21 → $16 | +654.68% | Mar 15, 2024 |
| Needham | Needham | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +607.51% | Mar 15, 2024 |
| TD Cowen | TD Cowen | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 15, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.